MD-SHOULDER

MD-SHOULDER is an injectable class III medical device:
- Barrier effect, lubricating activity and mechanical support during other drug therapies.
- It promotes muscle relaxation, supports muscle structures and relieves localised or movement-induced pain.
- It can be combined with other treatments.

- GUNA S.P.A.
- NAME: MD-SHOULDER
- COMPOSITION: Collagen, Iris, Sodium chloride, Water for injection preparations.
- PRESENTATION: 10 x 2ml.
- INDICATIONS: Effectively reduces pain and improves joint mobility of the shoulder and upper limb.
- INJECTION DEPTH: Peri-articular administration: insert the needle close to the joint to a minimum depth of 13-25 mm. Intra-articular administration: insert the needle below the lower edge of the posterior angle of the acromion, directing it towards the coracoid process.
- PROTOCOL: 1-2 infiltrations per week to limit the physiological deterioration of joints and tissues (tendons and ligaments). Results are evident from the third to the fifth week.
- USE: Strict medical use.

- Vials: 10 x 2ml.

Shoulder and upper limb.

Collagen, Iris, Sodium chloride, Water for injectable preparations.

- Before proceeding with treatment, make a differential diagnosis of the shoulder: e.g. pain that may result from chronic cervical syndrome, ischaemic heart disease (especially for the left shoulder), cholecystitis/cholelithiasis (especially for the right shoulder).
- The product must be administered by qualified healthcare personnel using correct technique (skin disinfection, choice of needle/injection position) to avoid local complications.
- Although well-tolerated, local redness or a burning/pain sensation in the injection area may occur, which generally resolves within 5-10 minutes.
- Use with caution if rehabilitation sessions are planned immediately after injection: in some cases, immediate mobilisation of the treated area may reduce the effectiveness of the device.

- In general, there are not many contraindications explicitly indicated for MD-SHOULDER, other than known hypersensitivity to the components of the product.
- Use is not recommended in the presence of septic processes in the joint (i.e. active joint infections) or other conditions that would contraindicate an intra-articular injection.

Scientific evidence demonstrates the efficacy and safety of MD-SHOULDER in the following cases:
- Glenohumeral arthrosis.
- Acromioclavicular arthrosis.
- Sternoclavicular arthrosis.
- Calcific tendonitis of the supra-spine.
- Acute scapulohumeral periarthritis and sub-deltoid bursitis.
- Injuries with partial thickening of the rotator cuff.
- Painful shoulder in patients with post-stroke haemiplegia.
- Subacromial conflict (shoulder impingement syndrome).
- Rotator cuff syndrome.
- Scapulohumeral dislocation.
- Epicondylitis resistant to other treatments.
- Contractures.
- Arthritic conditions:
- due to ageing
- due to incorrect posture
- due to concomitant chronic diseases
- due to trauma and injuries